Literature DB >> 6334046

Modification of the radiation sensitivity of human tumour cells by a bis-benzimidazole derivative.

P J Smith, C O Anderson.   

Abstract

A comparison was made of the ability of either X-radiation or a DNA-specific ligand (the vital bis-benzimidazole dye; Hoechst 33342) to induce: cell killing, inhibition of de novo DNA synthesis, DNA strand breakage and the delay of cell division in human colon adenocarcinoma cells in vitro. Unlike radiation-induced cell killing, ligand-induced cytotoxicity appeared to be positively correlated with the extent of inhibition of de novo DNA synthesis--a feature consistent with the persistent binding of ligand molecules to nuclear DNA. Ligand-induced DNA strand-breaks disappeared slowly although ligand-treated cells retained apparently normal capacities to repair discrete radiogenic DNA strand-breaks. Pre-treatment of cells with Hoechst 33342 resulted in a dose-modifying enhancement of radiation resistance not associated with altered dosimetry for strand-break induction. However, radioresistance was accompanied by the protracted retention of cells in the G2 phase of the cell cycle. We suggest that the results provide direct evidence that the retention of cells in G2 phase is a sparing phenomenon and is triggered by the responses of chromatin domains to the presence of DNA damage. Our results have implications for the use of DNA-interactive agents in combined modalities for tumour therapy, and indicate a possible basis for the sparing of some tumour cells in dividing populations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334046     DOI: 10.1080/09553008414551511

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  9 in total

1.  Radioprotection by DNA ligands.

Authors:  R F Martin; S Broadhurst; S D'Abrew; R Budd; R Sephton; M Reum; D P Kelly
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  A DNA topoisomerase II-independent route for novobiocin-mediated resistance to DNA binding agents.

Authors:  P J Smith; S M Bell
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Radioprotective Effect of Beta D-Glucan and Vitamin E on Gamma Irradiated Mouse.

Authors:  Faraj Tabeie; Seyed Mehdi Tabatabaei; Ali Mahmoud-Pashazadeh; Majid Assadi
Journal:  J Clin Diagn Res       Date:  2017-02-01

4.  Radiation sensitivity of tumour cells stained in vitro or in vivo with the bisbenzimide fluorochrome Hoechst 33342.

Authors:  S D Young; R P Hill
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

5.  Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse.

Authors:  M J Trotter; P L Olive; D J Chaplin
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

6.  The live cell DNA stain SiR-Hoechst induces DNA damage responses and impairs cell cycle progression.

Authors:  Onur Sen; Adrian T Saurin; Jonathan M G Higgins
Journal:  Sci Rep       Date:  2018-05-21       Impact factor: 4.379

7.  DNA-targeted 2-nitroimidazoles: in vitro and in vivo studies.

Authors:  D S Cowan; J F Matejovic; R A McClelland; A M Rauth
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

8.  Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours.

Authors:  P L Olive; D J Chaplin; R E Durand
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640

9.  Radioprotection of targeted and bystander cells by methylproamine.

Authors:  Susanne Burdak-Rothkamm; Andrea Smith; Pavel Lobachevsky; Roger Martin; Kevin M Prise
Journal:  Strahlenther Onkol       Date:  2014-09-23       Impact factor: 3.621

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.